AI
ANIK icon

Atria Investments’s Anika Therapeutics ANIK Stock Holding History

Atria Investments’s Portfolio ANIK Stock Details ANIK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-13,096
Closed -$139K – 2010
2025
Q2 		$139K Buy
13,096
+2,118
+19% +$26.7K ﹤0.01% 1950
2025
Q1 		$165K Buy
+10,978
New +$183K ﹤0.01% 1844
2024
Q4 		– Sell
-8,831
Closed -$218K – 1851
2024
Q3 		$218K Buy
+8,831
New +$229K ﹤0.01% 1787
2020
Q1 		– Sell
-3,950
Closed -$205K – 597
2019
Q4 		$205K Buy
+3,950
New +$229K 0.01% 1145
2017
Q4 		– Sell
-4,986
Closed -$289K – 816
2017
Q3 		$289K Sell
4,986
-645
-11% -$33.7K 0.02% 619
2017
Q2 		$278K Buy
5,631
+68
+1% +$3.13K 0.02% 586
2017
Q1 		$242K Buy
5,563
+679
+14% +$32.4K 0.02% 586
2016
Q4 		$239K Buy
+4,884
New +$226K 0.02% 548

Other funds holding ANIK

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
TI
Trigran Investments Northbrook, Illinois $418M AUM 3.34% 1-Year Est. Return
CP
Caligan Partners New York $1.41B AUM 518.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
CM
Capital Management Glen Allen, Virginia $585M AUM 5.18% 1-Year Est. Return
BFM
Boothbay Fund Management New York $4.34B AUM 106.31% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return